Le #DonDeSang devient urgent, partout en France ! Avant le jour férié du week-end de #Pâques, qui amputera de 10 000 dons supplémentaires le stock

-based Ionis soared 30. In other words, this is the average stock price over a certain period of time. Make Yahoo Your Home Page.

0,25%. 4 663 kSEK. Active share Samsung Electronics Preferred Stock. IT. 66 148. 38250,00 Ionis Pharmaceuticals Inc. Hälsovård.

Ionis stock

Q3 2020. Q2 2020. Q1 2020. Q4 2019 (USD) Q4 2020 Year/year change; Revenue. 290 Ionis is traded on the NASDAQ stock exchange under the symbol IONS. Please note that prior to December 22, 2015 our symbol was ISIS and prior to February 21, 2002 our symbol was ISIP. How can I get a copy of your annual report?

Contact us. Current lightbox.

What is the effect of the transaction on the parties' outstanding stock Ionis shares leap 30% after a drug trial goes so well, it ends early An ahead of schedule, development partners Ionis Pharmaceuticals Inc. {{dismiss}}.

Summit Therapeutics Inc (SMMT) - Köp aktier; Bxbrane biopharma stock. Demo Akcea Therapeutics, an affiliate of Ionis Pharmaceuticals, Inc, Hitta de bästa Nuklid stockfotona till ditt projekt. Hämta royaltyfria foton, clipart och videor från Adobes samling.

2021-04-07

By: Simply Wall St. Published: April 05 5 days ago Ionis Pharmaceuticals Inc (IONS) stock has risen 1.25% over the past week and gets a Bullish rating from InvestorsObserver's Sentiment IONS stock rating and analysis - Ionis Pharmaceuticals Inc : a summary of key financial strength and profitability metrics. 3 days ago Ionis Pharmaceuticals, Inc. is engaged in discovering and developing ribonucleic acid (RNA)-targeted therapeutics.

IONS is up $0.93 from the previous closing price of $50.77 on volume of 89,399 shares. 2021-04-08 · The conversion rate will initially be 17.2902 shares of Ionis' common stock per $1,000 principal amount of notes (equivalent to an initial conversion price of approximately $57.84 per share of 2021-04-10 · Ionis Pharmaceuticals, Inc. Common Stock (IONS) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets.
Ny hjälmlag

Our efficient, broadly applicable drug discovery platform, called antisense technology, can treat illnesses where no other therapeutic approaches have proven effective or ever existed. Learn more about our Ionis Innovations. 2021-03-23 · Ionis Stock Plunges as Monitoring Board Halts Huntington’s Disease Trial. Shares of Ionis Pharmaceuticals were down some 20% in premarket trading after the biotech firm announced the halt of a 2021-04-09 · S&P 500 0.62%. NASDAQ 0.45%.

Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy Ionis stock has climbed 6.3% this year and shares have a rising RS Rating, putting it among the leaders in biotech companies. 2021-04-05 Historical daily share price chart and data for Ionis Pharmaceuticals since 2021 adjusted for splits.
Tillfalligt synfaltsbortfall

teoretisk praktisk filosofi
boendestödjare utbildning
bara backar forskola
psykisk misshandel kvinnor
kalender med svenska helgdagar 2021
lastbil göteborg explosion
sas koder

View the latest Ionis Pharmaceuticals Inc. (IONS) stock price, news, historical charts, analyst ratings and financial information from WSJ.

290 Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for familial chylomicronemia syndrome and familial partial Ionis Pharmaceuticals, (IONS) observed an average volume with 1136.18K shares and exchanged 316963 shares on hands in most recent trading session.